Ovarian steroid hormones: what's hot in the stem cell pool?

Por Cittelly, Diana M, Richer, Jennifer K, Sartorius, Carol A
Publicado em 2010

miR-200c Targets a NF-κB Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer

Por Howe, Erin N., Cochrane, Dawn R., Cittelly, Diana M., Richer, Jennifer K.
Publicado em 2012

Detrimental effects of anti-apoptotic treatments in spinal cord injury

Por Cittelly, Diana M, Nesic, Olivera, Johnson, Kathia, Hulsebosch, Claire, Perez-Polo, J. Regino
Publicado em 2007

Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies

Por Hanna, Colton, Kwok, Letty, Finlay-Schultz, Jessica, Sartorius, Carol A., Cittelly, Diana M.
Publicado no J Vis Exp (2016)

Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors

Por Cittelly, Diana M., Das, Partha M., Salvo, Virgilio A., Fonseca, Juan P., Burow, Matthew E., Jones, Frank E.
Publicado em 2010

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors

Por Cittelly, Diana M, Das, Partha M, Spoelstra, Nicole S, Edgerton, Susan M, Richer, Jennifer K, Thor, Ann D, Jones, Frank E
Publicado em 2010

Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a

Por Finlay-Schultz, Jessica, Cittelly, Diana M., Hendricks, Peter, Patel, Purvi, Kabos, Peter, Jacobsen, Britta M., Richer, Jennifer K., Sartorius, Carol A.
Publicado no Oncogene (2014)

Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4

Por Cittelly, Diana M., Finlay-Schultz, Jessica, Howe, Erin N., Spoelstra, Nicole S., Axlund, Sunshine Daddario, Hendricks, Peter, Jacobsen, Britta M., Sartorius, Carol A., Richer, Jennifer K.
Publicado no Oncogene (2012)

MicroRNAs Link Estrogen Receptor Alpha Status and Dicer Levels in Breast Cancer

Por Cochrane, Dawn R., Cittelly, Diana M., Howe, Erin N., Spoelstra, Nicole S., McKinsey, Erin L., LaPara, Kelly, Elias, Anthony, Yee, Douglas, Richer, Jennifer K.
Publicado no Horm Cancer (2010)

Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism

Por Sartorius, Carol A., Hanna, Colton T., Gril, Brunilde, Cruz, Hazel, Serkova, Natalie J., Huber, Kendra M., Kabos, Peter, Schedin, Troy B., Borges, Virginia F., Steeg, Patricia S., Cittelly, Diana M.
Publicado no Oncogene (2015)

Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel

Por Cittelly, Diana M., Dimitrova, Irina, Howe, Erin N., Cochrane, Dawn R., Jean, Annie, Spoelstra, Nicole S., Post, Miriam D., Lu, Xian, Broaddus, Russell R., Spillman, Monique A., Richer, Jennifer K.
Publicado em 2012

Fibroblast subtypes regulate responsiveness of luminal breast cancer to estrogen

Por Brechbuhl, Heather M., Finlay-Schultz, Jessica, Yamamoto, Tomomi M., Gillen, Austin E., Cittelly, Diana M., Tan, Aik C., Sams, Sharon, Pillai, Manoj M., Elias, Anthony D., Robinson, William A., Sartorius, Carol A., Kabos, Peter
Publicado no Clin Cancer Res (2016)

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide

Por Cochrane, Dawn R, Bernales, Sebastián, Jacobsen, Britta M, Cittelly, Diana M, Howe, Erin N, D’Amato, Nicholas C, Spoelstra, Nicole S, Edgerton, Susan M, Jean, Annie, Guerrero, Javier, Gómez, Francisco, Medicherla, Satyanarayana, Alfaro, Iván E, McCullagh, Emma, Jedlicka, Paul, Torkko, Kathleen C, Thor, Ann D, Elias, Anthony D, Protter, Andrew A, Richer, Jennifer K
Publicado em 2014